BI-9564 is a potent and selective inhibitor of the c-Met kinase, which plays a key role in tumor growth, metastasis, and angiogenesis. It is primarily used in cancer research to study signaling pathways involved in cell proliferation and survival. Due to its high specificity, BI-9564 serves as a valuable tool compound in preclinical studies aiming to evaluate the therapeutic potential of c-Met inhibition in various cancers, including lung, liver, and gastric carcinomas. It is also utilized in combination studies with other targeted therapies to assess synergistic effects and overcome drug resistance. Its application remains confined to laboratory and experimental settings, supporting the development of new oncology treatments.